Annual EBITDA
-$496.63M$74.66M+13.07%
Summary
- Current Value
- As of today, BBIO annual EBITDA is -$496.63M, up +13.07% on
- Historical Performance
- BBIO annual EBITDA is down -7.57% over the past 3 years, down -5.35% over the past 5 years
- All-Time High Comparison
- BBIO annual EBITDA is currently -1039.11% below its historical high of -$43.60M set on
- 3-Year Low Comparison
- BBIO annual EBITDA is +16.24% above its 3-year low of -$592.95M reached on
- Sector Comparison
- BBIO annual EBITDA is higher than 1.81% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$496.63M | +13.1% | -7.6% | -5.3% | -1039.1% | |
| Quarterly EBITDA | -$104.77M | -2.2% | +13.5% | +36.9% | -150.6% | |
| TTM EBITDA | -$498.88M | +26.5% | -15.0% | +7.3% | -1093.2% | |
| Price | $66.26 | +98.6% | +381.9% | +11.9% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $502.08M | +126.3% | +546.6% | +5986.5% | +100.0% | |
| Annual EPS | -$3.79 | -31.5% | -16.0% | +0.5% | -1124.5% | |
| -$502.06M | +13.0% | -7.2% | -5.8% | -1044.8% | ||
| Annual Net Income | -$732.94M | -34.9% | -51.2% | -45.0% | -1572.2% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$461.67M | N/A | -7.6% |
| 5Y | -$461.67M | -7.6% | |
| All | -$43.60M | -1039.1% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$592.95M | +16.2% | |
| 5Y | -$592.95M | +16.2% | |
| All | -$592.95M | +16.2% |
EBITDA History
| Year | Value | Change |
|---|---|---|
| -$496.63M | +13.1% | |
| -$571.29M | +3.7% | |
| -$592.95M | -28.4% | |
| -$461.67M | +19.1% | |
| -$570.79M | -21.1% |
| Year | Value | Change |
|---|---|---|
| -$471.39M | -77.1% | |
| -$266.24M | -45.0% | |
| -$183.66M | -321.3% | |
| -$43.60M | - |
FAQ
What is the current annual EBITDA of BBIO?
As of today, BBIO annual EBITDA is -$496.63M
What is 1-year change in BBIO annual EBITDA?
BBIO annual EBITDA is up +13.07% year-over-year
What is 3-year change in BBIO annual EBITDA?
BBIO annual EBITDA is down -7.57% over the past 3 years
How far is BBIO annual EBITDA from its all-time high?
BBIO annual EBITDA is currently -1039.11% below its historical high of -$43.60M set on December 31, 2017
How does BBIO annual EBITDA rank versus sector peers?
BBIO annual EBITDA is higher than 1.81% of companies in Healthcare sector
When is BBIO next annual earnings release?
As of today, the next annual earnings release for BBIO has not been scheduled
Quarterly EBITDA
-$104.77M$22.23M+17.50%
Summary
- Current Value
- As of today, BBIO quarterly EBITDA is -$104.77M, up +17.50% on
- Historical Performance
- BBIO quarterly EBITDA is down -2.20% year-over-year, up +13.53% over the past 3 years
- All-Time High Comparison
- BBIO quarterly EBITDA is currently -2062.35% below its historical high of $5.34M set on
- 3-Year Low Comparison
- BBIO quarterly EBITDA is +52.37% above its 3-year low of -$219.97M reached on
- Sector Comparison
- BBIO quarterly EBITDA is higher than 3.04% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$104.77M | +17.5% | -2.2% | +13.5% | +36.9% | |
| Annual EBITDA | -$496.63M | – | +13.1% | -7.6% | -5.3% | |
| TTM EBITDA | -$498.88M | -0.5% | +26.5% | -15.0% | +7.3% | |
| Price | $66.26 | -0.3% | +98.6% | +381.9% | +11.9% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $194.52M | +26.2% | +66.8% | +10000.0% | +10000.0% | |
| Quarterly EPS | -$0.84 | +15.5% | +4.3% | +8.3% | +28.4% | |
| -$105.96M | +17.5% | -2.1% | +13.7% | +36.7% | ||
| Quarterly Net Income | -$166.56M | +14.4% | +1.8% | -16.7% | +2.6% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$102.52M | N/A | -2.2% |
| 3Y | $5.34M | -2062.3% | |
| 5Y | $5.34M | -2062.3% | |
| All | $5.34M | -2062.3% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$134.96M | +22.4% | |
| 3Y | -$219.97M | +52.4% | |
| 5Y | -$219.97M | +52.4% | |
| All | -$219.97M | +52.4% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of BBIO?
As of today, BBIO quarterly EBITDA is -$104.77M
What is BBIO quarterly EBITDA most recent change?
BBIO quarterly EBITDA was up +17.50% on March 31, 2026
What is 1-year change in BBIO quarterly EBITDA?
BBIO quarterly EBITDA is down -2.20% year-over-year
How far is BBIO quarterly EBITDA from its all-time high?
BBIO quarterly EBITDA is currently -2062.35% below its historical high of $5.34M set on March 31, 2024
How does BBIO quarterly EBITDA rank versus sector peers?
BBIO quarterly EBITDA is higher than 3.04% of companies in Healthcare sector
When is BBIO next earnings release?
The next earnings release for BBIO is on
TTM EBITDA
-$498.88M$2.25M-0.45%
Summary
- Current Value
- As of today, BBIO TTM EBITDA is -$498.88M, down -0.45% on
- Historical Performance
- BBIO TTM EBITDA is up +26.54% year-over-year, down -15.03% over the past 3 years
- All-Time High Comparison
- BBIO TTM EBITDA is currently -1093.16% below its historical high of -$41.81M set on
- 3-Year Low Comparison
- BBIO TTM EBITDA is +26.54% above its 3-year low of -$679.15M reached on
- Sector Comparison
- BBIO TTM EBITDA is higher than 1.66% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$498.88M | -0.5% | +26.5% | -15.0% | +7.3% | |
| Annual EBITDA | -$496.63M | – | +13.1% | -7.6% | -5.3% | |
| Quarterly EBITDA | -$104.77M | +17.5% | -2.2% | +13.5% | +36.9% | |
| Price | $66.26 | -0.3% | +98.6% | +381.9% | +11.9% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $579.96M | +15.5% | +355.2% | +645.6% | +6557.8% | |
| TTM EPS | -$3.75 | +1.0% | -6.1% | -32.1% | +10.8% | |
| -$504.22M | -0.4% | +26.4% | -14.5% | +6.5% | ||
| TTM Net Income | -$729.89M | +0.4% | -7.8% | -71.3% | -27.5% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$496.63M | -0.5% | |
| 3Y | -$433.70M | N/A | -15.0% |
| 5Y | -$433.70M | -15.0% | |
| All | -$41.81M | -1093.2% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$679.15M | N/A | +26.5% |
| 3Y | -$679.15M | +26.5% | |
| 5Y | -$679.15M | +26.5% | |
| All | -$679.15M | +26.5% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of BBIO?
As of today, BBIO TTM EBITDA is -$498.88M
What is BBIO TTM EBITDA most recent change?
BBIO TTM EBITDA was down -0.45% on March 31, 2026
What is 1-year change in BBIO TTM EBITDA?
BBIO TTM EBITDA is up +26.54% year-over-year
How far is BBIO TTM EBITDA from its all-time high?
BBIO TTM EBITDA is currently -1093.16% below its historical high of -$41.81M set on March 31, 2018
How does BBIO TTM EBITDA rank versus sector peers?
BBIO TTM EBITDA is higher than 1.66% of companies in Healthcare sector
When is BBIO next earnings release?
The next earnings release for BBIO is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- BBIO Official Website bridgebio.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1743881/000174388126000009/0001743881-26-000009-index.htm
- BBIO Profile on Yahoo Finance finance.yahoo.com/quote/BBIO
- BBIO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bbio